Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CUE Cue Biopharma, Inc.

未开盘 03-02 16:00:00 EST

0.2823

+0.0022

+0.79%

盘后0.2799

-0.0024-0.85%

18:44 EST

最高0.3000	最低0.2710	成交量18.28万
今开0.2710	昨收0.2801	日振幅10.35%
总市值2,576万	流通市值2,568万	总股本9,124万
成交额5.16万	换手率0.20%	流通股本9,097万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CUE","market":"US","secType":"STK","nameCN":"Cue Biopharma, Inc.","latestPrice":0.2823,"timestamp":1772485200000,"preClose":0.2801,"halted":0,"volume":182831,"hourTrading":{"tag":"盘后","latestPrice":0.2799,"preClose":0.2823,"latestTime":"18:44 EST","volume":2501,"amount":700.1879,"timestamp":1772495046596,"change":-0.0024,"changeRate":-0.008502,"amplitude":0.008502},"delay":0,"changeRate":0.007854337736522598,"floatShares":90972099,"shares":91237736,"eps":-0.43659,"marketStatus":"未开盘","change":0.0022,"latestTime":"03-02 16:00:00 EST","open":0.271,"high":0.3,"low":0.271,"amount":51559.61816038001,"amplitude":0.103534,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.43659,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772528400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1514869200000,"exchange":"NASDAQ","adjPreClose":0.2801,"preHourTrading":{"tag":"盘前","latestPrice":0.29,"preClose":0.2801,"latestTime":"09:16 EST","volume":4327,"amount":1250.34774724,"timestamp":1772460980190,"change":0.0099,"changeRate":0.035345,"amplitude":0.067833},"postHourTrading":{"tag":"盘后","latestPrice":0.2799,"preClose":0.2823,"latestTime":"18:44 EST","volume":2501,"amount":700.1879,"timestamp":1772495046596,"change":-0.0024,"changeRate":-0.008502,"amplitude":0.008502},"volumeRatio":0.627331,"impliedVol":0.7367,"impliedVolPercentile":0.704},"requestUrl":"/m/hq/s/CUE","defaultTab":"news","newsList":[{"id":"2616364138","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616364138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616364138?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:33","pubTimestamp":1772462029,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时33分，Cue Biopharma, Inc.股票出现波动，股价急速上涨5.78%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Rallybio Corporation、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Xeris制药涨幅较大，Ensysce Biosciences, Inc.、Rallybio Corporation、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为74.33%、27.13%、19.78%，振幅较大的相关个股有Rallybio Corporation、Ensysce Biosciences, Inc.、Edesa Biotech, Inc.，振幅分别为15.52%、13.14%、12.27%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223349a4428e36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223349a4428e36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"1183818806","title":"Cue Biopharma公布CUE-401治疗自身免疫及炎症性疾病的临床前安全性与耐受性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1183818806","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183818806?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:01","pubTimestamp":1771333272,"startTime":"0","endTime":"0","summary":"Cue Biopharma近日披露了其候选药物CUE-401针对自身免疫及炎症性疾病的临床前研究结果，重点展示了该药物在安全性和耐受性方面的积极数据。这些发现为后续临床试验的推进提供了重要依据，标志着公司在免疫疗法领域取得新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"2604910287","title":"Cue Biopharma, Inc.盘中异动 急速上涨8.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604910287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604910287?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:30","pubTimestamp":1768573831,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日22时30分，Cue Biopharma, Inc.股票出现波动，股价快速拉升8.16%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Jaguar Health, Inc.、Immunitybio, Inc.、Iterum Therapeutics Plc涨幅较大，Jaguar Health, Inc.、Biodexa Pharmaceuticals Plc、Genprex, Inc.较为活跃，换手率分别为719.29%、104.48%、8.59%，振幅较大的相关个股有Immunitybio, Inc.、Jaguar Health, Inc.、Skye Bioscience, Inc.，振幅分别为8.23%、7.85%、6.91%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223031a4cc71d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223031a4cc71d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"1139800107","title":"新闻稿：Cue Biopharma宣布拟公开发行股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1139800107","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139800107?lang=zh_cn&edition=full","pubTime":"2025-12-19 05:04","pubTimestamp":1766091890,"startTime":"0","endTime":"0","summary":"波士顿，2025年12月18日—— Cue Biopharma, Inc.是一家临床阶段的生物制药公司，致力于开发一种新型治疗生物制剂，以选择性地介入和调节针对特定疾病的T细胞，从而治疗自身免疫性疾病。今天，公司宣布将开始进行一项由承销商承保的公开发行，发行其普通股及随附的购买普通股的认股权证。此外，Cue Biopharma计划给予承销商在30天内购买最多15%额外普通股和/或认股权证的选择权。所有证券均由Cue Biopharma发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","CUE","BK4139","BK4232"],"gpt_icon":0},{"id":"2583658089","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.41%报0.653美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583658089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583658089?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:51","pubTimestamp":1763135497,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日23时51分，Cue Biopharma, Inc.股票出现异动，股价急速上涨5.41%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Cidara Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cypherpunk Technologies Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Cypherpunk Technologies Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为911.19%、178.67%、123.05%，振幅较大的相关个股有Cypherpunk Technologies Inc.、Hcw Biologics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为69.31%、59.44%、46.41%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142351389504ce3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142351389504ce3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"1141314391","title":"Immunoscape与Cue Biopharma达成许可协议 开发新型疗法以攻克实体肿瘤癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=1141314391","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141314391?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:16","pubTimestamp":1763057789,"startTime":"0","endTime":"0","summary":"Immunoscape与Cue Biopharma达成许可协议，旨在开发新型疗法以攻击实体肿瘤癌症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4585","LU1023059063.AUD","BK4599","LU0289739699.SGD","LU1983299246.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4581","LU2112291526.USD","BK4534","IE0009355771.USD","CUE","BK4533","LU2242652126.USD","BK4566","BK4588","IE00BJJMRZ35.SGD","LU1061106388.HKD","IE00B2B36J28.USD","AMGN","LU0109394709.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0058720904.USD","LU2242646821.SGD","IE0002141913.USD","BK4139","LU1571399168.USD","SG9999001440.SGD","LU2468319806.SGD","LU0868494617.USD"],"gpt_icon":0},{"id":"2579168325","title":"Cue Biopharma, Inc.盘中异动 急速下挫6.44%报0.690美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579168325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579168325?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:18","pubTimestamp":1761765532,"startTime":"0","endTime":"0","summary":"北京时间2025年10月30日03时18分，Cue Biopharma, Inc.股票出现异动，股价急速跳水6.44%。截至发稿，该股报0.690美元/股，成交量17.0052万股，换手率0.22%，振幅7.99%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Purple Biotech Ltd、Ernexa Therapeutics Inc.、Aditxt, Inc.较为活跃，换手率分别为4337.21%、2629.91%、451.77%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Ernexa Therapeutics Inc.、Purple Biotech Ltd，振幅分别为139.33%、96.79%、93.83%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510300318529748f744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510300318529748f744&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2574458620","title":"Cue Biopharma, Inc.盘中异动 快速跳水5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574458620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574458620?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:53","pubTimestamp":1760108029,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时53分，Cue Biopharma, Inc.股票出现异动，股价快速下跌5.95%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Quoin Pharmaceuticals Ltd、Gyre Therapeutics, Inc.、Q32 Bio Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aditxt, Inc.、Cdt Equity Inc.较为活跃，换手率分别为724.18%、325.12%、72.28%，振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为368.75%、39.68%、33.20%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022535094c20855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022535094c20855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"1131090074","title":"Cue Biopharma, Inc.宣布战略性领导层调整，助力颠覆性自身免疫疗法候选药物进入下一发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1131090074","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131090074?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:02","pubTimestamp":1759150966,"startTime":"0","endTime":"0","summary":"Cue Biopharma, Inc.宣布战略性领导层调整，助力颠覆性自身免疫疗法候选药物进入下一发展阶段","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"2568138262","title":"Cue Biopharma, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568138262","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568138262?lang=zh_cn&edition=full","pubTime":"2025-09-20 03:58","pubTimestamp":1758311897,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日03时58分，Cue Biopharma, Inc.股票出现波动，股价快速跳水5.33%。截至发稿，该股报0.691美元/股，成交量19.1478万股，换手率0.25%，振幅4.70%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Tharimmune, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Adverum Biotechnologies, Inc.涨幅较大，Clearmind Medicine Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为692.68%、192.10%、184.34%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Tharimmune, Inc.，振幅分别为65.63%、59.00%、50.94%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920035817979db26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920035817979db26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2568225193","title":"吴向东直播CUE热点：差点以为旁边餐饮大佬是贾国龙来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2568225193","media":"酒业内参","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568225193?lang=zh_cn&edition=full","pubTime":"2025-09-19 17:44","pubTimestamp":1758275040,"startTime":"0","endTime":"0","summary":"9月19日大珍·珍酒正式上市，珍酒李渡董事长吴向东在直播中CUE热点：差点以为旁边餐饮大佬是贾国龙来了。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：李思阳","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/chanjing/jync/2025-09-19/doc-infqzqqf2940509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1132","BK4139","08496","CUE"],"gpt_icon":0},{"id":"2518208806","title":"Cue Biopharma, Inc.盘中异动 快速下挫8.18%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208806?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613723,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Cue Biopharma, Inc.股票出现波动，股价大幅跳水8.18%。截至发稿，该股报1.01美元/股，成交量1860股，换手率0.00%，振幅6.36%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2175.89%、425.85%、66.65%，振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进，振幅分别为100.05%、98.72%、98.49%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213523abf2fdc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213523abf2fdc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2517410939","title":"Cue Biopharma, Inc.盘中异动 股价大跌5.98%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517410939?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:33","pubTimestamp":1741192408,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时33分，Cue Biopharma, Inc.股票出现异动，股价大幅跳水5.98%。截至发稿，该股报1.10美元/股，成交量5.9574万股，换手率0.09%，振幅5.09%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Radiopharm Theranostics Limited涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为910.00%、295.77%、280.58%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003328963af864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003328963af864&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2516860878","title":"Cue Biopharma, Inc.盘中异动 早盘急速下跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516860878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516860878?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:24","pubTimestamp":1741101852,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时24分，Cue Biopharma, Inc.股票出现异动，股价大幅跳水5.00%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1174.66%、1135.75%、688.19%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为100.00%、68.71%、66.67%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232412a25f145e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232412a25f145e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2514373841","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373841?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:46","pubTimestamp":1740753978,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时46分，Cue Biopharma, Inc.股票出现异动，股价急速下挫6.79%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Immunitybio, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为512.97%、340.10%、276.59%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.，振幅分别为45.32%、31.14%、29.25%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822461898967dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822461898967dd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2514622668","title":"Cue Biopharma, Inc.盘中异动 下午盘大幅上涨6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514622668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514622668?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:25","pubTimestamp":1740601524,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时25分，Cue Biopharma, Inc.股票出现波动，股价快速上涨6.40%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6834.47%、330.23%、264.27%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270425249893ea39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270425249893ea39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2514013048","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌6.93%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013048?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:54","pubTimestamp":1740495259,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时54分，Cue Biopharma, Inc.股票出现异动，股价急速下挫6.93%。截至发稿，该股报1.18美元/股，成交量2.4041万股，换手率0.04%，振幅7.09%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为960.57%、701.50%、552.96%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts ，振幅分别为100.27%、46.65%、42.76%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225419962ff7fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225419962ff7fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"2514377374","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514377374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514377374?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:27","pubTimestamp":1740410844,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时27分，Cue Biopharma, Inc.股票出现波动，股价急速下跌5.30%。截至发稿，该股报1.25美元/股，成交量1.8319万股，换手率0.03%，振幅3.92%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为201.25%、84.67%、27.77%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232724a25221f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232724a25221f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"2512448070","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512448070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512448070?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:54","pubTimestamp":1739987645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时54分，Cue Biopharma, Inc.股票出现波动，股价大幅上涨5.80%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为647.10%、251.00%、218.61%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为250.83%、159.49%、52.00%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200154069628edb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200154069628edb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"2512198059","title":"Cue Biopharma, Inc.盘中异动 股价大跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512198059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512198059?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:59","pubTimestamp":1739901545,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时59分，Cue Biopharma, Inc.股票出现异动，股价急速跳水6.04%。截至发稿，该股报1.40美元/股，成交量6.415万股，换手率0.10%，振幅7.68%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为619.16%、192.23%、162.16%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015905a24ad87e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015905a24ad87e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cuebiopharma.com","stockEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":-0.1568},{"period":"3month","weight":-0.5057},{"period":"6month","weight":-0.644},{"period":"1year","weight":-0.7705},{"period":"ytd","weight":-0.0756}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cue Biopharma, Inc.于2014年12月31日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，设计了一类新型的注射疗法，以选择性地在患者体内直接参与和调节靶向的、与疾病相关的T细胞。该公司的愿景是通过生成一类新的T细胞接合剂，用于选择性调节疾病特异性T细胞，将大自然的信号或“线索”转化为蛋白质疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.050638},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.057224},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.042372},{"month":4,"riseRate":0.5,"avgChangeRate":0.067443},{"month":5,"riseRate":0.375,"avgChangeRate":0.000175},{"month":6,"riseRate":0.25,"avgChangeRate":-0.112726},{"month":7,"riseRate":0.375,"avgChangeRate":-0.091669},{"month":8,"riseRate":0.5,"avgChangeRate":-0.020243},{"month":9,"riseRate":0.375,"avgChangeRate":-0.04952},{"month":10,"riseRate":0.5,"avgChangeRate":0.074591},{"month":11,"riseRate":0.625,"avgChangeRate":0.074714},{"month":12,"riseRate":0.375,"avgChangeRate":-0.083168}],"exchange":"NASDAQ","name":"Cue Biopharma, Inc.","nameEN":"Cue Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cue Biopharma, Inc.(CUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cue Biopharma, Inc.,CUE,Cue Biopharma, Inc.股票,Cue Biopharma, Inc.股票老虎,Cue Biopharma, Inc.股票老虎国际,Cue Biopharma, Inc.行情,Cue Biopharma, Inc.股票行情,Cue Biopharma, Inc.股价,Cue Biopharma, Inc.股市,Cue Biopharma, Inc.股票价格,Cue Biopharma, Inc.股票交易,Cue Biopharma, Inc.股票购买,Cue Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cue Biopharma, Inc.(CUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}